Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>JIUYUAN GENE (02566.HK) Public Offering ~675x Oversubscribed; 1-lot Success Rate 20%
Recommend 20 Positive 20 Negative 23 |
||||
|
||||
|
JIUYUAN GENE (02566.HK) announced its offering results. The public offering recorded 675.83 times subscription, with a one-lot (200 shares) success rate of 20.01%. The international offering recorded 1.18 times subscription. Under the clawback mechanism, the public offering has increased to 22.6994 million shares, representing 50% of the total number of shares offered. The final offer price was $12.42, raising net proceeds of $485 million. The shares are expected to be listed on Thursday (28th). Chinese biopharmaceutical company JIUYUAN GENE proposed to offer 45.3988 million shares globally, with Hong Kong public offering accounting for 10%. The offer price ranged from $11.48 to $12.56 per share. The seven cornerstone investors include FOSUN PHARMA (02196.HK)'s Fosun Industrial and ALI HEALTH (00241.HK)'s Alibaba Health HK, which collectively subscribed $350 million worth of the company's shares. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
